This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2000:476:57-66.

doi: 10.1007/978-1-4615-4221-6_5.

Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis

G Breier¹

Affiliations

PMID: 10949655
DOI: 10.1007/978-1-4615-4221-6_5

Review

Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis

G Breier. Adv Exp Med Biol. 2000.

. 2000:476:57-66.

doi: 10.1007/978-1-4615-4221-6_5.

Author

G Breier¹

Affiliation

¹ Department of Molecular Cell Biology, Max-Planck-Institut für physiologische und klinische Forschung, Bad Nauheim, Germany.

PMID: 10949655
DOI: 10.1007/978-1-4615-4221-6_5

No abstract available

PubMed Disclaimer

Similar articles

Signaling vascular morphogenesis and maintenance.
Hanahan D. Hanahan D. Science. 1997 Jul 4;277(5322):48-50. doi: 10.1126/science.277.5322.48. Science. 1997. PMID: 9229772 No abstract available.
Endothelial receptor tyrosine kinases involved in angiogenesis.
Mustonen T, Alitalo K. Mustonen T, et al. J Cell Biol. 1995 May;129(4):895-8. doi: 10.1083/jcb.129.4.895. J Cell Biol. 1995. PMID: 7538139 Free PMC article. Review. No abstract available.
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G, Vigneri P, Mariani L, Butó S, Collini P, Pilotti S, Pierotti MA, Bongarzone I. Bunone G, et al. Am J Pathol. 1999 Dec;155(6):1967-76. doi: 10.1016/S0002-9440(10)65515-0. Am J Pathol. 1999. PMID: 10595926 Free PMC article.
Receptor links blood vessels, axons.
Roush W. Roush W. Science. 1998 Mar 27;279(5359):2042. doi: 10.1126/science.279.5359.2042. Science. 1998. PMID: 9537914 No abstract available.
Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA, Paavonen K. Partanen TA, et al. Microsc Res Tech. 2001 Oct 15;55(2):108-21. doi: 10.1002/jemt.1162. Microsc Res Tech. 2001. PMID: 11596156 Review.

See all similar articles

Cited by

Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J, Liu JH, Liu H, Liao XZ, Chen Y, Lin MG, Gu YY, Liu TL, Wang DM, Ge H, Mo SL. Xie J, et al. BMC Cancer. 2016 Nov 18;16(1):899. doi: 10.1186/s12885-016-2921-x. BMC Cancer. 2016. PMID: 27863471 Free PMC article.
Mathematical modeling of tumor-induced angiogenesis.
Mantzaris NV, Webb S, Othmer HG. Mantzaris NV, et al. J Math Biol. 2004 Aug;49(2):111-87. doi: 10.1007/s00285-003-0262-2. Epub 2004 Feb 6. J Math Biol. 2004. PMID: 15293017 Review. No abstract available.
sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.
Kim BR, Seo SH, Park MS, Lee SH, Kwon Y, Rho SB. Kim BR, et al. Oncotarget. 2015 Oct 13;6(31):31830-43. doi: 10.18632/oncotarget.5570. Oncotarget. 2015. PMID: 26378810 Free PMC article.
The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
Park MS, Kim BR, Dong SM, Lee SH, Kim DY, Rho SB. Park MS, et al. Oncotarget. 2014 Jul 15;5(13):4935-44. doi: 10.18632/oncotarget.2064. Oncotarget. 2014. PMID: 24952732 Free PMC article.
The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer.
Dakir el-H, Pickard A, Srivastava K, McCrudden CM, Gross SR, Lloyd S, Zhang SD, Margariti A, Morgan R, Rudland PS, El-Tanani M. Dakir el-H, et al. Oncotarget. 2018 Oct 9;9(79):34889-34910. doi: 10.18632/oncotarget.26175. eCollection 2018 Oct 9. Oncotarget. 2018. PMID: 30405882 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer